UTRS

Minerva Surgical, Inc. UTRS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode UTRS ACON FOXO WORX DRMA AKAN RNAZ
6M 0.00 % 39.08 % -99.95 % -62.68 % 418.01 % -31.82 % 26.61 %
YTD 0.00 % -90.98 % -99.98 % -83.82 % 201.12 % -55.62 % -79.29 %
1Y -99.17 % -92.64 % -99.96 % -74.78 % 224.46 % -63.24 % -96.82 %
3Y -100.00 % -99.99 % -100.00 % -97.08 % -97.42 % -99.64 % -100.00 %
5Y -100.00 % -100.00 % -100.00 % -98.71 % -99.66 % -99.99 % -100.00 %
10Y -100.00 % -100.00 % -100.00 % -99.98 % -99.66 % -99.99 % -100.00 %
From the beginning -100.00 % -100.00 % -100.00 % -99.98 % -99.66 % -99.99 % -100.00 %

Dividend